Developer docs
API playgroundTry for free, no card

Search company profiles

Cerba Research

Full company profile

uuid0007lav

Namestring
Cerba Research
Legal namestring
Cerba Research NV
Company typeenum
Private
Founded yearint
1970
Descriptiontext

Cerba Research is a private, Belgium-headquartered clinical research laboratory services provider founded in 1970, operating from its registered office in Zwijnaarde (Ghent). The company serves the global pharmaceutical, biotechnology, and vaccine development industries through an integrated specialty and central clinical trial laboratory platform. Cerba Research maintains 14 core laboratories and 31 partner laboratories across five continents (42+ facilities total), with harmonized SOPs enabling consistent data quality across North America, Europe, Asia-Pacific, Africa, and Australia. Since 2018, the company has supported more than 1,400 clinical trials and currently runs 300+ ongoing studies, with 210+ of those in oncology.

The company's technology stack spans flow cytometry (BD FACSLyric, Cytek Aurora), next-generation sequencing (Illumina, Element, Oxford Nanopore), digital pathology (HALO, Visiopharm), spatial omics (NanoString GeoMx DSP), multiplex IHC/IF, and immunoassay platforms. Validated proprietary assets include 250+ IHC biomarkers, 160 biomarker targets, and specialized panels such as HISTOPROFILE-TRM for solid tumor phenotyping. Cerba Xpert, a biobank sub-brand, provides access to 40,000+ well-characterized samples, while the Frépillon facility in France houses 2.4 million+ samples under regulatory-aligned SOPs. The portfolio is anchored by multi-jurisdictional accreditations including CAP, CLIA, ISO 15189, ISO 13485, ISO 27001, GLP, GCLP, SANAS, NATA/RCPA, and NGSP Level 1.

Cerba Research generates revenue through professional services contracts with pharmaceutical and biotechnology sponsors conducting clinical development programs, with pricing structured around study requirements, sample volumes, and geographic scope. Distribution is direct enterprise sales with recommended early engagement at protocol design, supported by a scientist-to-scientist engagement model, an active conference presence (AACR, ASH, ESMO, ISCT, World Vaccine Congress, with 20+ events planned for 2026), and a scientific content engine (blogs, white papers, peer-reviewed publications at a cadence of approximately 30 per year). The company employs 5,001-10,000 people globally and serves primary customer segments of pharmaceutical companies, biotechnology companies, life science companies, and vaccine developers across therapeutic areas including oncology, infectious diseases, cell and gene therapy, inflammation and immunology, metabolics, neuroscience, and rare diseases.

Short descriptiontext

Cerba Research is a Belgium-headquartered specialty and central clinical trial laboratory serving pharmaceutical, biotechnology, and vaccine developers globally through 42+ labs across five continents, offering integrated biomarker, genomics, flow cytometry, histopathology, and bioanalytical testing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersGhent, Belgium
HQ citystring
Ghent
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices16 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial laboratory, central lab services, biomarker testing, specialty diagnostics, clinical research services
Industry3 codes
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code3 codes
  • Medical Laboratories621511
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Clinical Trial Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Specialty Laboratory Testing Services
TypeProfessional Services
Description

Cerba Research provides specialty laboratory testing including flow cytometry, genomics, biomarkers, immunoassays, and histopathology for clinical trials. Revenue is generated through service contracts with pharmaceutical and biotechnology companies conducting clinical development programs.

cerbaresearch.com
2Central Laboratory Services
TypeProfessional Services
Description

Global central laboratory services for clinical trials including sample logistics, project management, protocol development, and safety testing across all trial phases.

cerbaresearch.com
3Custom Assay Development
TypeProfessional Services
Description

Custom assay development and validation services for specific biomarker testing requirements, supporting regulatory submissions and clinical trial endpoints.

cerbaresearch.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Cerba Xpert
Description

Biobank repository providing access to over 40,000 well-characterized prospective and retrospective samples, including diverse biofluids and tissues, with the Frépillon biobank facility housing over 2.4 million samples.

cerbaresearch.com
Core offering1 text field

Cerba Research provides central laboratory services for clinical trials, including biomarker discovery, specialty testing, bioanalytical services, and sample management for pharmaceutical, biotechnology, and vaccine developers. The company supports early-phase through late-phase clinical studies with integrated testing platforms, scientific expertise, and global logistics. It operates as the dedicated clinical research arm of Cerba HealthCare, offering end-to-end lab solutions that span study setup, sample analysis, data delivery, and post-trial storage.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1400+ clinical trials supported since 2018
+3 more records
Product overview1 text field

Cerba Research is a clinical research laboratory services provider offering an integrated platform combining specialty laboratory expertise with central lab scale and global reach. The core portfolio includes specialty laboratory solutions (anatomic pathology, assay development, bioanalytical solutions, biomarker solutions, data intelligence, flow cytometry, genomics, immunoassay, pre-clinical services, pre-analytical/PBMC processing, and virology/vaccine laboratory) alongside central laboratory solutions (clinical trial lab services, global laboratory network, logistics, project management, protocol development, safety testing). Key add-on services include Cerba Xpert Biobank for sample access and Data Quality & Accreditation for regulatory compliance. The company operates through 14 core laboratories and 31 partner labs across five continents, providing consistent, harmonized assay results from early discovery through regulatory submission, particularly for oncology, infectious diseases, cell and gene therapy, and rare diseases.

Product and service7 records
1Central Laboratory Services
CategoryCentral Lab Services
Description

End-to-end central lab services for global clinical trials, including routine safety testing, custom kit assembly, sample logistics, and standardized data delivery for pharmaceutical and biotech sponsors.

2Biomarker Services
CategoryBiomarker Development
Description

Biomarker discovery, assay development, validation, and clinical-sample testing supporting companion diagnostics, patient stratification, and mechanism-of-action studies across therapeutic areas.

3Specialty Testing Services
CategorySpecialty Diagnostics
Description

Specialty immunology, microbiology, molecular biology, flow cytometry, and cell-based assays performed on clinical trial samples to support immunology, infectious disease, and oncology programs.

4Bioanalytical Services
CategoryBioanalytical Services
Description

Bioanalytical method development, validation, and sample analysis for pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity testing across all clinical phases.

5Vaccine and Infectious Disease Services
CategoryVaccine Testing
Description

Specialized lab services for vaccine developers and infectious disease programs, including immunogenicity assays, neutralizing antibody testing, pathogen detection, and correlates-of-protection analyses.

6Sample Management and Biorepository
CategorySample Management
Description

Long-term storage, biorepository management, and chain-of-custody services for clinical trial biospecimens, including biological samples, derivatives, and reference materials.

7Genomics and Molecular Services
CategoryGenomics Services
Description

Genomics, next-generation sequencing (NGS), and molecular profiling services supporting translational research, patient stratification, and genomic biomarker programs in clinical trials.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global central and specialty clinical trial laboratory formed from Quintiles and Quest Diagnostics. Most direct competitor to Cerba Research, offering comparable central lab, biomarker, genomic, and flow cytometry services for clinical trials worldwide.

TypeDirect peer
Description

Major clinical trial central laboratory with global footprint and integrated CRO services. Directly comparable to Cerba Research on central lab scale and multinational trial support across therapeutic areas including oncology.

TypeDirect peer
Description

Large global CRO with substantial central laboratory and specialty biomarker capabilities. Competes with Cerba Research for full-service and specialty lab contracts on multinational clinical trials.

TypeDirect peer
Description

Contract research organization providing bioanalytical, biomarker, and central laboratory services for clinical trials. Directly comparable to Cerba Research's specialty lab offerings and has been actively acquiring in the central lab space.

TypeBroad incumbent
Description

Large CRO with discovery, safety, and manufacturing services, including clinical and bioanalytical lab capabilities. Comparable to Cerba Research on the lab services overlap but operates a much broader life-sciences portfolio.

TypeDirect peer
Description

Global central laboratory network providing clinical trial testing across multiple continents. Directly comparable to Cerba Research's central lab model with similarly broad geographic reach.

TypeBroad incumbent
Description

Largest life-sciences tools and CRO platform; PPD's central lab competes with Cerba Research, though it is part of a much broader product/services portfolio rather than a focused lab specialist.

TypeEmerging player
Description

Mid-sized CRO with growing central lab and biomarker capabilities serving biotech-led clinical trials. Comparable to Cerba Research's biotech customer segment and full-service trial support model.

TypeEmerging player
Description

Mid-sized global CRO with central laboratory and specialty biomarker services for Phase I-IV trials. Comparable to Cerba Research on the full-service biotech/pharma client base and specialty lab integration.

TypeDirect peer
Description

Independent central and specialty clinical trial laboratory offering esoteric testing, microbiology, and biomarker services. Closely comparable to Cerba Research's specialty + central lab integration model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries17 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance13 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cerba Research

Clinical Trial Laboratory Servicescerbaresearch.com

Cerba Research is a Belgium-headquartered specialty and central clinical trial laboratory serving pharmaceutical, biotechnology, and vaccine developers globally through 42+ labs across five continents, offering integrated biomarker, genomics, flow cytometry, histopathology, and bioanalytical testing services.

What Cerba Research does

Cerba Research is a private, Belgium-headquartered clinical research laboratory services provider founded in 1970, operating from its registered office in Zwijnaarde (Ghent). The company serves the global pharmaceutical, biotechnology, and vaccine development industries through an integrated specialty and central clinical trial laboratory platform. Cerba Research maintains 14 core laboratories and 31 partner laboratories across five continents (42+ facilities total), with harmonized SOPs enabling consistent data quality across North America, Europe, Asia-Pacific, Africa, and Australia. Since 2018, the company has supported more than 1,400 clinical trials and currently runs 300+ ongoing studies, with 210+ of those in oncology.

The company's technology stack spans flow cytometry (BD FACSLyric, Cytek Aurora), next-generation sequencing (Illumina, Element, Oxford Nanopore), digital pathology (HALO, Visiopharm), spatial omics (NanoString GeoMx DSP), multiplex IHC/IF, and immunoassay platforms. Validated proprietary assets include 250+ IHC biomarkers, 160 biomarker targets, and specialized panels such as HISTOPROFILE-TRM for solid tumor phenotyping. Cerba Xpert, a biobank sub-brand, provides access to 40,000+ well-characterized samples, while the Frépillon facility in France houses 2.4 million+ samples under regulatory-aligned SOPs. The portfolio is anchored by multi-jurisdictional accreditations including CAP, CLIA, ISO 15189, ISO 13485, ISO 27001, GLP, GCLP, SANAS, NATA/RCPA, and NGSP Level 1.

Cerba Research generates revenue through professional services contracts with pharmaceutical and biotechnology sponsors conducting clinical development programs, with pricing structured around study requirements, sample volumes, and geographic scope. Distribution is direct enterprise sales with recommended early engagement at protocol design, supported by a scientist-to-scientist engagement model, an active conference presence (AACR, ASH, ESMO, ISCT, World Vaccine Congress, with 20+ events planned for 2026), and a scientific content engine (blogs, white papers, peer-reviewed publications at a cadence of approximately 30 per year). The company employs 5,001-10,000 people globally and serves primary customer segments of pharmaceutical companies, biotechnology companies, life science companies, and vaccine developers across therapeutic areas including oncology, infectious diseases, cell and gene therapy, inflammation and immunology, metabolics, neuroscience, and rare diseases.

Cerba Research firmographics

Firmographics
Name
Cerba Research
Legal name
Cerba Research NV
Website
https://cerbaresearch.com
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
251–500 employees
Short description
Cerba Research is a Belgium-headquartered specialty and central clinical trial laboratory serving pharmaceutical, biotechnology, and vaccine developers globally through 42+ labs across five continents, offering integrated biomarker, genomics, flow cytometry, histopathology, and bioanalytical testing services.
Ownership category
akta.pro rank

Cerba Research industry classification

Industry
Product category
Clinical Trial Laboratory Services
NAICS
Medical Laboratories (621511), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Clinical trial laboratory
  • Central lab services
  • Biomarker testing
  • Specialty diagnostics
  • Clinical research services

Where Cerba Research is headquartered

Location

Headquarters

HQ city
Ghent
HQ country
Belgium
HQ region
Europe

Offices16 records

Markets served

Cerba Research business model

Business model
GTM type
B2B
Offering type
Services

Revenue model

  1. Specialty Laboratory Testing Services: Cerba Research provides specialty laboratory testing including flow cytometry, genomics, biomarkers, immunoassays, and histopathology for clinical trials. Revenue is generated through service contracts with pharmaceutical and biotechnology companies conducting clinical development programs.
  2. Central Laboratory Services: Global central laboratory services for clinical trials including sample logistics, project management, protocol development, and safety testing across all trial phases.
  3. Custom Assay Development: Custom assay development and validation services for specific biomarker testing requirements, supporting regulatory submissions and clinical trial endpoints.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Cerba Research product offering

Product offering

Core offering

Cerba Research provides central laboratory services for clinical trials, including biomarker discovery, specialty testing, bioanalytical services, and sample management for pharmaceutical, biotechnology, and vaccine developers. The company supports early-phase through late-phase clinical studies with integrated testing platforms, scientific expertise, and global logistics. It operates as the dedicated clinical research arm of Cerba HealthCare, offering end-to-end lab solutions that span study setup, sample analysis, data delivery, and post-trial storage.

Product overview

Cerba Research is a clinical research laboratory services provider offering an integrated platform combining specialty laboratory expertise with central lab scale and global reach. The core portfolio includes specialty laboratory solutions (anatomic pathology, assay development, bioanalytical solutions, biomarker solutions, data intelligence, flow cytometry, genomics, immunoassay, pre-clinical services, pre-analytical/PBMC processing, and virology/vaccine laboratory) alongside central laboratory solutions (clinical trial lab services, global laboratory network, logistics, project management, protocol development, safety testing). Key add-on services include Cerba Xpert Biobank for sample access and Data Quality & Accreditation for regulatory compliance. The company operates through 14 core laboratories and 31 partner labs across five continents, providing consistent, harmonized assay results from early discovery through regulatory submission, particularly for oncology, infectious diseases, cell and gene therapy, and rare diseases.

Differentiator

Problem solved

Functional benefit

Brands

  • Cerba Xpert: Biobank repository providing access to over 40,000 well-characterized prospective and retrospective samples, including diverse biofluids and tissues, with the Frépillon biobank facility housing over 2.4 million samples.

Products and services

  • Central Laboratory Services End-to-end central lab services for global clinical trials, including routine safety testing, custom kit assembly, sample logistics, and standardized data delivery for pharmaceutical and biotech sponsors.
  • Biomarker Services Biomarker discovery, assay development, validation, and clinical-sample testing supporting companion diagnostics, patient stratification, and mechanism-of-action studies across therapeutic areas.
  • Specialty Testing Services Specialty immunology, microbiology, molecular biology, flow cytometry, and cell-based assays performed on clinical trial samples to support immunology, infectious disease, and oncology programs.
  • Bioanalytical Services Bioanalytical method development, validation, and sample analysis for pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity testing across all clinical phases.
  • Vaccine and Infectious Disease Services Specialized lab services for vaccine developers and infectious disease programs, including immunogenicity assays, neutralizing antibody testing, pathogen detection, and correlates-of-protection analyses.
  • Sample Management and Biorepository Long-term storage, biorepository management, and chain-of-custody services for clinical trial biospecimens, including biological samples, derivatives, and reference materials.
  • Genomics and Molecular Services Genomics, next-generation sequencing (NGS), and molecular profiling services supporting translational research, patient stratification, and genomic biomarker programs in clinical trials.

Quantifiable outcome

  • 1400+ clinical trials supported since 2018
  • +3 more outcomes

Companies that use Cerba Research

Customer profile

Segments4 records

Ideal customer profiles3 records

Cerba Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Cerba Research partnerships and signals

Strategic signal

Scale indicators12 records

Recent moves8 records

Expansion highlights6 records

Cerba Research competitors and assessment

Company assessment

Direct peers

  • IQVIA Laboratories (Q² Solutions): Global central and specialty clinical trial laboratory formed from Quintiles and Quest Diagnostics. Most direct competitor to Cerba Research, offering comparable central lab, biomarker, genomic, and flow cytometry services for clinical trials worldwide.
  • Labcorp Drug Development (Fortrea): Major clinical trial central laboratory with global footprint and integrated CRO services. Directly comparable to Cerba Research on central lab scale and multinational trial support across therapeutic areas including oncology.
  • ICON plc (incl. PRA Health Sciences): Large global CRO with substantial central laboratory and specialty biomarker capabilities. Competes with Cerba Research for full-service and specialty lab contracts on multinational clinical trials.
  • Frontage Laboratories: Contract research organization providing bioanalytical, biomarker, and central laboratory services for clinical trials. Directly comparable to Cerba Research's specialty lab offerings and has been actively acquiring in the central lab space.
  • Eurofins Central Laboratory: Global central laboratory network providing clinical trial testing across multiple continents. Directly comparable to Cerba Research's central lab model with similarly broad geographic reach.
  • ACM Global Laboratories: Independent central and specialty clinical trial laboratory offering esoteric testing, microbiology, and biomarker services. Closely comparable to Cerba Research's specialty + central lab integration model.

Broad incumbents

  • Charles River Laboratories: Large CRO with discovery, safety, and manufacturing services, including clinical and bioanalytical lab capabilities. Comparable to Cerba Research on the lab services overlap but operates a much broader life-sciences portfolio.
  • Thermo Fisher Scientific (PPD Clinical Research): Largest life-sciences tools and CRO platform; PPD's central lab competes with Cerba Research, though it is part of a much broader product/services portfolio rather than a focused lab specialist.

Emerging players

  • Medpace Holdings: Mid-sized CRO with growing central lab and biomarker capabilities serving biotech-led clinical trials. Comparable to Cerba Research's biotech customer segment and full-service trial support model.
  • Worldwide Clinical Trials: Mid-sized global CRO with central laboratory and specialty biomarker services for Phase I-IV trials. Comparable to Cerba Research on the full-service biotech/pharma client base and specialty lab integration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Cerba Research social profiles

Digital presence

Cerba Research compliance and trust

Trust signal

Compliance13 records

Cerba Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cerba Research leadership team

Management profile

Number of profiles

Cerba Research subsidiaries and ownership

Company hierarchy

Subsidiaries17 records

Cerba Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cerba Research M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cerba Research

What does Cerba Research do?

Cerba Research provides central laboratory services for clinical trials, including biomarker discovery, specialty testing, bioanalytical services, and sample management for pharmaceutical, biotechnology, and vaccine developers. The company supports early-phase through late-phase clinical studies with integrated testing platforms, scientific expertise, and global logistics. It operates as the dedicated clinical research arm of Cerba HealthCare, offering end-to-end lab solutions that span study setup, sample analysis, data delivery, and post-trial storage.

Is Cerba Research a public or private company?

Cerba Research is a private company. It is classified as private equity controlled and is currently operating.

When was Cerba Research founded?

Cerba Research was founded in 1970. It employs 251 to 500 people.

Where is Cerba Research based?

Cerba Research is headquartered in Ghent, Belgium, in the Europe region.

How does Cerba Research make money?

Three revenue lines are on record. Specialty Laboratory Testing Services are the primary driver. The others are central Laboratory Services and custom Assay Development.

Who are Cerba Research's main competitors?

Direct peers on record are IQVIA Laboratories (Q² Solutions), Labcorp Drug Development (Fortrea), ICON plc (incl. PRA Health Sciences), Frontage Laboratories, Eurofins Central Laboratory and ACM Global Laboratories. Broad incumbents are Charles River Laboratories and Thermo Fisher Scientific (PPD Clinical Research). Emerging players are Medpace Holdings and Worldwide Clinical Trials.

Does Cerba Research have an API?

No public API is recorded for Cerba Research.

What industry is Cerba Research in?

Cerba Research's product category is Clinical Trial Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooCentral Labs - Global Strategic Business Report: $1.4 Billion Expansion to $4.4 Billion by 2032 as AI and Precision Medicine Reshape Competition Among Labcorp, Eurofins Scientific, ICON, IQVIA and Cerba ResearchThe global Central Labs market is projected to grow from $3.0 billion in 2025 to $4.4 billion by 2032, a CAGR of 5.8%. Genetic services are forecast to reach $1.4 billion by 2032, with China expanding at 9.3% annually.News-MedicalHow to standardize Ki67 assessment using AI-powered image analysisA study authored by researchers from Cerba Research compared two AI image analysis platforms, Aiforia and Halo, against manual pathologist scoring for Ki67 immunohistochemistry in 192 solid tumor samples. The findings demonstrated a high correlation between the two AI platforms (r=0.95), with both platforms showing more consistent results compared to inter-pathologist variability. The researchers concluded that AI-based platforms can help standardize Ki67 assessment and reduce inter-observer variability in clinical analysis of solid tumors.PR NewswireIVDR Process Overview with Case-study on IVDR Implementation for Custom LDT Assays, Upcoming Webinar Hosted by XtalksXtalks announced a free webinar scheduled for June 9, 2026 to provide an end-to-end overview of In Vitro Diagnostic Regulation (IVDR) compliance for custom Laboratory Developed Test (LDT) assays, featuring experts from Cerba Research. The session will cover method development, design control, validation parameters, and technical dossier preparation for CE marking. The webinar aims to help laboratories understand IVDR requirements and reduce regulatory risk when implementing custom LDT assays.News-MedicalA specialty laboratory perspective on ESGCTCerba Research experts presented recent advancements in cell and gene therapy monitoring, including new qPCR assays for Ad5 vector shedding and sequencing techniques for tracking vector integration sites, at the 31st European Society of Gene and Cell Therapy Congress. The presentations highlighted the role of these laboratory solutions in ensuring the safety and efficacy of genome-editing therapies for rare diseases and cardiovascular conditions. Cerba Research emphasized its capability to support clinical trials through in-house developed diagnostic tools for pre-clinical and post-marketing surveillance.News-MedicalThe potential to optimize laboratory testing and operations with automation and AICerba Research's Coen Stalpers discusses using AI to automate laboratory processes, citing a script that reduced data transfer from four hours to two minutes. The automation cuts data transfer time by about 16 hours daily and reduces consumable use tenfold. He also highlights future potential for AI-driven long-term trend analysis.News-MedicalLeveraging the power of automation to boost researchCerba Research implemented an automated kit-building line using RFID tags, achieving 100% accuracy and doubling efficiency. The system halts production on discrepancies, and the company plans to expand kit capacity and digitize processes in 2025.FiercePharmaLaboratory services poised for the digital revolutionCerba Research, a specialty laboratory services provider, has appointed Piet Jamaels as its new chief operating officer to lead the company's digital transformation, leveraging automation, AI, and big data analytics to modernize clinical trials management. Under Jamaels' leadership, the company is integrating a unified enterprise system and building on its recent acquisition of Viroclinics-DDL, a specialist virology and vaccine development contract research organization, which has expanded Cerba Research's reach into new geographies including North America, Asia, and Africa. GlobalData analysis shows decentralized clinical trials increased by 50% between 2020 and 2021, with at least 5% of trials in 2023 containing decentralized components, signaling a sector-wide shift that Cerba Research aims to capitalize on.News-MedicalCerba Research expands expertise and global reach to support drug developmentCerba Research, a clinical trial laboratory service provider, expanded its expertise and global reach by acquiring Viroclinics-DDL and Cirion Biopharma Research. The combined entity now offers a worldwide network of over 1,000 labs, data from more than 85 million patients, and the ability to sequence over 1,000 whole human genomes per week.News-MedicalProject management is key to successful clinical developmentCerba Research offers project management for clinical trials, assigning a dedicated Global Project Manager and core team to each client. The company uses a central global study database for real-time data access and a governance framework to monitor performance. It aims to optimize protocols from translational research through commercialization.News-MedicalCerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint VentureCerba Research and Teddy Lab signed a Memorandum of Understanding to discuss a joint venture, building on their collaboration since 2012. The agreement aims to expand services in China and enable cross-border clinical trial support. The JV would leverage Teddy's mainland China presence and Cerba's scientific expertise.